NPPA Approves 20% Price Hike for Serum Institute's BCG, Measles Vaccines
India's drug price regulator, NPPA, has approved a 20% price increase for Serum Institute of India's BCG, measles, and measles-rubella vaccines. This decision is unusual given the company's market dominance and comes after Serum Institute argued for the hike due to rising costs and the vaccines' critical public health importance.













